Skip to main content
Stallion India Fluorochemicals Limited logo

Stallion India Fluorochemicals Limited — Investor Relations & Filings

Ticker · STALLION ISIN · INE0RYC01010 LEI · 984500B14436A38CDA57 BSE.NS Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2026-05-22 Call Transcript
Country IN India
Listing BSE.NS STALLION

About Stallion India Fluorochemicals Limited

https://stallionfluorochemicals.com

Stallion India Fluorochemicals Limited specializes in the manufacturing, processing, and distribution of fluorochemicals and refrigerant gases. The company provides a comprehensive range of products including hydrofluorocarbons (HFCs), hydrochlorofluorocarbons (HCFCs), and specialty gases tailored for diverse applications. Its core offerings serve the heating, ventilation, air conditioning, and refrigeration (HVAC&R) sectors, as well as the automotive and industrial cooling markets. Stallion operates advanced refilling and blending facilities, ensuring high purity standards and compliance with international environmental regulations. The company distinguishes itself through a robust supply chain network and technical expertise in gas management, positioning itself as a key supplier for diverse industrial requirements.

Recent filings

Filing Released Lang Actions
Transcript of the Investor Conference for the business and financial performance of the Company for the Quarter & Financial Year ended on 31st March, 2026.
Call Transcript Classification · 90% confidence The document is an intimation under SEBI LODR Regulation 30 attaching the full transcript of the Q4 and FY25-26 earnings conference call, including management remarks and Q&A. This fits the definition of a Call Transcript.
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-22 English
As per the attachment.
Regulatory Filings Classification · 87% confidence The document is a SEBI‐mandated Monitoring Agency Report on the utilisation of IPO proceeds for the quarter ended March 31, 2026, addressed to stock exchanges. It is a compliance filing rather than an earnings release, management discussion, capital raise announcement, or shareholder vote. There is no category specifically for “Monitoring Agency Reports,” so under the fallback for regulatory compliance filings it best fits “Regulatory Filings (RNS).”
2026-05-19 English
Monitoring Agency Report
Regulatory Filings Classification · 85% confidence The document is a Monitoring Agency Report submitted to the stock exchanges pursuant to SEBI Listing Obligations and Disclosure Requirements and Issue of Capital & Disclosure Requirements Regulations. It provides a compliance‐style update on the utilisation of IPO proceeds for the quarter ended March 31, 2026. It is not an interim financial report (IR) or an earnings release, nor is it announcing a new share issue (SHA) or dividend (DIV). It is a mandated regulatory compliance filing, falling under the general “Regulatory Filings” category, which covers miscellaneous compliance documents submitted to exchanges.
2026-05-19 English
As per the attachment.
Report Publication Announcement Classification · 85% confidence The document is a short regulatory disclosure letter (<5,000 characters) to the stock exchanges notifying that the audio recording of the earnings conference call has been made available via a link. It does not contain any financial data or analysis itself and simply announces publication of the call recording. Under the “menu vs meal” rule, this is an announcement of publication rather than the report (transcript) itself, so the correct category is Report Publication Announcement (RPA).
2026-05-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a letter addressed to stock exchanges (NSE and BSE) informing them about the availability of the audio recording of an earnings conference call held on 18th May 2026. The call discussed the audited financial results for the quarter and financial year ended 31st March 2026. The document provides a link to the audio recording and requests acknowledgment. The document itself is not the transcript or the earnings release but an announcement about the availability of the audio recording of the call. The document length is short (1534 characters), and it serves as a notification rather than containing substantive financial data or the transcript itself. Therefore, the appropriate classification is Call Transcript (CT) because it relates to the earnings conference call, but since it only announces the audio recording availability and does not contain the transcript, the best fit is Regulatory Filings (RNS) as a fallback for such announcements. However, given the content specifically relates to the earnings call audio recording, the closest specific category is Call Transcript (CT) with moderate confidence, but considering the document is only an announcement, Regulatory Filings (RNS) is more accurate. Given the instructions, announcements about availability of recordings are best classified as Regulatory Filings (RNS).
2026-05-19 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.